A link between the dopamine neurotransmitter system in the brain and an individual’s ability to recognize faces has been uncovered by new research.  Using a combination of functional magnetic resonance imaging (fMRI) and positron emission tomography (PET) imaging, researchers discovered that individuals who showed more brain activity per unit of dopamine showed better facial recognition. {read more here}

PET scans performed three months after chemoradiation treatment for vulvar cancer can be valuable for predicting overall likelihood of survival as well as the risk of local and distant disease recurrence, according to a study presented on Monday at the American Society for Radiation Oncology (ASTRO) meeting in Boston. {read more here}

There’s a new way to detect the buildup of tau proteins in living brains, according to  research published in the journal  Brain. The method uses PET imaging to see in which regions of the brain the protein is accumulating. It may also possibly reveal clues about the potential for Alzheimer’s or other tau-related cognitive diseases in individual patients—and pave the way for new types of Alzheimer’s drugs.  {read more here}

FluoroPharma Medical Inc. (OTCQB: FPMI) announced today that data from its Phase II clinical trial for CardioPET were presented at the 21st Annual Meeting of the American Society of Nuclear Cardiology on September 24th, 2016 in Boca Raton, Florida. {read more here}